Suboptimal Clinical Response Rates with Newer Antibiotics Among Patients with Moderate Renal Impairment: Review of the Literature and Potential Pharmacokinetic and Pharmacodynamic Considerations for Observed Findings

A Monte Carlo Simulation Approach for Beta-Lactam Dosing in Critically Ill Patients Receiving Prolonged Intermittent Renal Replacement Therapy

(2018) Soo Min Jang et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Innovative Use of Novel Biomarkers to Improve the Safety of Renally Eliminated and Nephrotoxic Medications

(2018) Erin F. Barreto et al.   PHARMACOTHERAPY

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016

(2017) Andrew Rhodes et al.   INTENSIVE CARE MEDICINE

Efficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program

(2016) John E. Mazuski et al.   CLINICAL INFECTIOUS DISEASES

Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI)

(2015) Joseph Solomkin et al.   CLINICAL INFECTIOUS DISEASES

Telavancin for Hospital-Acquired Pneumonia: Clinical Response and 28-Day Survival

(2014) G. Ralph Corey et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients

(2014) Jan J. De Waele et al.   INTENSIVE CARE MEDICINE

Impact of Bolus Dosing versus Continuous Infusion of Piperacillin and Tazobactam on the Development of Antimicrobial Resistance in Pseudomonas aeruginosa

(2013) T. W. Felton et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Retooling the Creatinine Clearance Equation to Estimate Kinetic GFR when the Plasma Creatinine Is Changing Acutely

(2013) S. Chen   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

β-Lactam therapeutic drug monitoring in the critically ill: optimising drug exposure in patients with fluctuating renal function and hypoalbuminaemia

(2012) Yoshiro Hayashi et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Antibiotic dosing in critically ill patients with acute kidney injury

(2011) Rachel F. Eyler et al.   Nature Reviews Nephrology

Telavancin versus Vancomycin for Hospital-Acquired Pneumonia due to Gram-positive Pathogens

(2010) E. Rubinstein et al.   CLINICAL INFECTIOUS DISEASES

Telavancin Versus Vancomycin for the Treatment of Complicated Skin and Skin‐Structure Infections Caused by Gram‐Positive Organisms

(2008) Martin E. Stryjewski et al.   CLINICAL INFECTIOUS DISEASES